Evaluation of GERD symptoms during therapy: Part II. Psychometric evaluation and validation of the new questionnaire ReQuest™ in erosive GERD

Digestion

Volumn 69, Issue 4, 2004, Pages 238-244

  Monnikes H ^a,f   Bardhan, K D ^b   Stanghellini, V ^c   Berghofer P ^d   Bethke, T D ^d   Armstrong, D ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d ALTANA PHARMA AG   (Germany)

^e MCMASTER UNIVERSITY   (Canada)

^f FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Gastroesophageal reflux disease; Gastrointestinal Symptom Rating Scale; Outcome measure; Psychological General Well Being scale; ReQuest validity; Symptom assessment, GERD; Treatment response, pantoprazole

Indexed keywords

PANTOPRAZOLE;

ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG RESPONSE; EVALUATION; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; PATIENT; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SELF EVALUATION; SYMPTOM; VALIDATION PROCESS; WELLBEING;

ENDPOINT DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 4344696648     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079708     Document Type: Article

References (20)

1. Feinstein AR: An additional basis for clinical medicine: IV. The development of clinimetrics. Ann Intern Med 1983;99:843-851.
2. Stanghellini V, Armstrong D, Mönnikes H, Bardhan KD: Systematic review: Do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther. 2004;19:463-479.
3. Moss SF, Armstrong D, Arnold R, Ferenci P, Fock KM, Holtmann G, McCarthy DM, Moraes-Filho JP, Mutschler E, Playford R, Spechler SJ, Stanghellini V, Modlin IM: GERD 2003 - A consensus on the way ahead. Digestion 2003;67:111-117.
4. Svedlund J, Sjödin I, Dotevall G: GSRS - A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-134.
5. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I: Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993;28:681-687.
6. Talley NJ, Fullerton S, Junghard O, Wiklund I: Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001;96:1998-2004.
7. Revicki DA, Crawley JA, Zodet MW, Levine DS, Joelsson BO: Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999;13:1621-1630.
8. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, Pare P, Chiba N, Leddin DS, Bigard MA, Colin R, Schoenfeld P: Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998;(583):41-49.
9. Wiklund I, Bardhan KD, Müller-Lissner S, Bigard MA, Bianchi Porro G, Ponce J, Hosie J, Scott M, Weir D, Fulton C, Gillon K, Peacock R: Quality of life during acute and intermittent treatment of gastrooesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group. Ital J Gastroenterol Hepatol 1998;30:19-27.
10. Revicki DA, Sorensen S, Maton PN, Orlando RC: Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease. Dig Dis 1998;16:284-291.
11. Bland JM, Altman DG: Cronbach's alpha. BMJ 1997;314:572.
12. Cohen J: Statistical Power Analysis for the behavioral Sciences, ed 2. Hillsdale, Erlbaum, 1998.
13. Carmines EG, Zeller RA: Reliability and Validity Assessment. Quantitative Applications in the Social Sciences. Beverly Hills, Sage, 1979.
14. Streiner RD, Norman GL: Health Measurement Scales: A Practical Guide to Their Development and Use, ed 2. Oxford, Oxford University Press, 1992, pp 220-235.
15. Johansson KE, Ask P, Boeryd B, Fransson SG, Tibbling L: Oesophagitis, signs of reflux, gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986;21:837-847.
16. Allen CJ, Parameswaran K, Belda J, Anvari M: Reproducibility, validity, and responsiveness of a disease-specific symptom questionnaire for gastroesophageal reflux disease. Dis Esophagus 2000;13:265-270.
17. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I: Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993;28:681-687.
18. Damiano A, Handley K, Adler E, Siddique R, Bhattacharyja A: Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment. Dig Dis Sci 2002;47:1530-1537.
19. Rothman M, Farup C, Stewart W, Helbers L, Zeldis J: Symptoms associated with gastroesophageal reflux disease: Development of a questionnaire for use in clinical trials. Dig Dis Sci 2001;46:1540-1549.
20. Williford WO, Krol WF, Spechler SJ: Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial. VA Cooperative Study Group on Gastroesophageal Reflux Disease (GERD). Control Clin Trials. 1994;15:335-348.